JCR Pharmaceuticals Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2022. For the year, the company expects net sales to be JPY 52,000 million. Operating income to be JPY 21,700 million. Earnings per share to be JPY 124.70. Profit attributable to owners of the parent to be JPY 15,400 million.